Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.88B |
| 2 |
Pfizer
PFE
|
+$1.41B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.17B |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.21B |
| 2 |
Adobe
ADBE
|
+$1.06B |
| 3 |
Stryker
SYK
|
+$955M |
| 4 |
Boston Scientific
BSX
|
+$695M |
| 5 |
Banco Santander
SAN
|
+$684M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
iShares Russell 2000 ETF
IWM
$79.8B
| $1.67M | ﹤0.01% |
6,718
-3,107
| -32% | -$801K |
|
602
Schwab International Equity ETF
SCHF
$66.6B
| $1.66M | ﹤0.01% |
67,140
+34,816
| +108% | +$886K |
|
603
American Electric Power
AEP
$69.6B
| $1.66M | ﹤0.01% |
12,669
+4,566
| +56% | +$571K |
|
604
iShares Core S&P Small-Cap ETF
IJR
$109B
| $1.66M | ﹤0.01% |
13,326
+1,942
| +17% | +$247K |
|
|
CLDT
605
Chatham Lodging
CLDT
$622M
| $1.65M | ﹤0.01% |
209,423
+30,918
| +17% | +$230K |
|
606
Archer Daniels Midland
ADM
$38.2B
| $1.65M | ﹤0.01% |
22,651
+5,553
| +32% | +$375K |
|
607
Ambev
ABEV
$48.1B
| $1.64M | ﹤0.01% |
562,474
-27,964
| -5% | -$79.9K |
|
608
Bank of Marin Bancorp
BMRC
$472M
| $1.64M | ﹤0.01% |
63,926
+11,499
| +22% | +$298K |
|
|
GRMN
609
Garmin
GRMN
$56.7B
| $1.63M | ﹤0.01% |
7,046
+69
| +1% | +$15.4K |
|
610
WisdomTree
WT
$2.96B
| $1.63M | ﹤0.01% |
112,132
+466
| +0.4% | +$7.2K |
|
611
Origin Bancorp
OBK
$1.69B
| $1.62M | ﹤0.01% |
39,171
+4,698
| +14% | +$196K |
|
612
Peoples Bancorp
PEBO
$1.5B
| $1.62M | ﹤0.01% |
49,396
-3,347
| -6% | -$108K |
|
613
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $1.62M | ﹤0.01% |
22,604
+4,232
| +23% | +$314K |
|
614
First Mid Bancshares
FMBH
$1.39B
| $1.62M | ﹤0.01% |
39,395
+5,333
| +16% | +$221K |
|
615
NIO
NIO
$12.2B
| $1.62M | ﹤0.01% |
268,325
+39,153
| +17% | +$198K |
|
616
Chubb
CB
$135B
| $1.61M | ﹤0.01% |
4,929
+40
| +0.8% | +$12.8K |
|
617
Aviat Networks
AVNW
$265M
| $1.59M | ﹤0.01% |
70,248
+38,529
| +121% | +$920K |
|
618
German American Bancorp
GABC
$1.91B
| $1.58M | ﹤0.01% |
37,792
-2,621
| -6% | -$108K |
|
619
Vanguard Energy ETF
VDE
$10.1B
| $1.57M | ﹤0.01% |
9,096
-388
| -4% | -$58.7K |
|
620
VanEck Pharmaceutical ETF
PPH
$959M
| $1.57M | ﹤0.01% |
15,148
-318
| -2% | -$33.9K |
|
621
Gilead Sciences
GILD
$162B
| $1.55M | ﹤0.01% |
11,150
-13,285
| -54% | -$1.86M |
|
622
Republic Services
RSG
$64.8B
| $1.55M | ﹤0.01% |
7,057
+177
| +3% | +$38.8K |
|
623
KraneShares CSI China Internet ETF
KWEB
$5.64B
| $1.53M | ﹤0.01% |
53,960
+7,692
| +17% | +$252K |
|
624
MGM Resorts International
MGM
$11.4B
| $1.51M | ﹤0.01% |
40,930
-6,524
| -14% | -$232K |
|
625
Atmos Energy
ATO
$28.8B
| $1.51M | ﹤0.01% |
8,174
+140
| +2% | +$24.7K |
|
Similar funds
Ken Fisher's Q1 2026 Portfolio in Review
As of Q1 2026, Ken Fisher held 1,133 positions worth $295B, up 0.65% from $293B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Fisher's Q1 2026 filing shows 116 new, 416 increased, 461 reduced and 117 closed positions. Its largest new stake was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M. The largest sale was Abbott, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q1 2026 buy was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M.
- Ken Fisher added most to AbbVie in Q1 2026, an estimated $1.88B increase.
- Ken Fisher's biggest Q1 2026 reduction was Abbott, cutting an estimated $1.21B.
- Ken Fisher fully exited Trip.com Group in Q1 2026, selling an estimated $175M.
- Ken Fisher's ten largest holdings make up 33% of its $295B portfolio in Q1 2026.
- Ken Fisher opened 116 new positions and closed 117 in Q1 2026.
- Ken Fisher's portfolio value rose 0.65% quarter-over-quarter to $295B.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.